The Rheumatology Podcast

Dr Andreas Diamantopoulos, Martina Hansens Hospital, Olso speaks to Dr Marwan Bukhari about his recently published paper on the use of colour duplex sonography in the routine care of GCA. They discuss the benefits of using of ultrasound in clinical diagnosis of GCA for early diagnosis and how this could be implemented in clinics.

Dr Andreas Diamantopoulos, Martina Hansens Hospital, Olso speaks to Dr Marwan Bukhari about his recently published paper on the use of colour duplex sonography in the routine care of GCA. They discuss the benefits of using of ultrasound in clinical diagnosis of GCA for early diagnosis and how this could be implemented in clinics.

Dr Marwan Bukhari and Prof Ian Bruce, University of Manchester, talk about his recently published paper on the results of the use of rituximab to treat refractory SLE from the BILAG biologics register. Prof Bruce is the chief investigator of the register, which observes patients going onto biologics for active disease. The focus of the study was to monitor the use of rituximab in SLE patients and gather real world evidence on the safety and efficacy of this. The study found that after 6 months of treatment 49% of patients showed a measurable response to treatment with rituximab, similar to what was observed in clinical trials.

Dr Marwan Bukhari and Prof Ian Bruce, University of Manchester, talk about his recently published paper on the results of the use of rituximab to treat refractory SLE from the BILAG biologics register. Prof Bruce is the chief investigator of the register, which observes patients going onto biologics for active disease. The focus of the study was to monitor the use of rituximab in SLE patients and gather real world evidence on the safety and efficacy of this. The study found that after 6 months of treatment 49% of patients showed a measurable response to treatment with rituximab, similar to what was observed in clinical trials.

Dr Marwan Bukhari and Prof Ian Bruce, University of Manchester, talk about his recently published paper on the results of the use of rituximab to treat refractory SLE from the BILAG biologics register. Prof Bruce is the chief investigator of the register, which observes patients going onto biologics for active disease. The focus of the study was to monitor the use of rituximab in SLE patients and gather real world evidence on the safety and efficacy of this. The study found that after 6 months of treatment 49% of patients showed a measurable response to treatment with rituximab, similar to what was observed in clinical trials.

Dr Marwan Bukhari and Prof Caroline Gordon, University of Birmingham, UK, discuss the recently published BSR guideline for the management of SLE in adults, the first guideline on the treatment of this condition. They discuss the evidence base for the guideline and recommendations for the diagnosis and treatment of patients with SLE.

Dr Marwan Bukhari and Prof Caroline Gordon, University of Birmingham, UK, discuss the recently published BSR guideline for the management of SLE in adults, the first guideline on the treatment of this condition. They discuss the evidence base for the guideline and recommendations for the diagnosis and treatment of patients with SLE.

Dr Marwan Bukhari and Prof Caroline Gordon, University of Birmingham, UK, discuss the recently published BSR guideline for the management of SLE in adults, the first guideline on the treatment of this condition. They discuss the evidence base for the guideline and recommendations for the diagnosis and treatment of patients with SLE.

Dr Marwan Bukhari talks to Prof Jon Giles, Columbia University, New York, USA, regarding his paper on the associations of muscle mass relative to fat mass with physical function in RA. Prof Giles states both his and his co-authors past research indicates that body composition, low muscle and high fat, is very strongly associated with physical function and, in some cases, more strongly associated with physical dysfunction thank the number of swollen and tender joints a patient has. He highlights the importance of considering muscle and fat mass impact on patients to improve physical function. They discuss the next steps to be taken to build on this research.

Dr Marwan Bukhari talks to Prof Jon Giles, Columbia University, New York, USA, regarding his paper on the associations of muscle mass relative to fat mass with physical function in RA. Prof Giles states both his and his co-authors past research indicates that body composition, low muscle and high fat, is very strongly associated with physical function and, in some cases, more strongly associated with physical dysfunction thank the number of swollen and tender joints a patient has. He highlights the importance of considering muscle and fat mass impact on patients to improve physical function. They discuss the next steps to be taken to build on this research.